Vimarsana
Biggest News Aggregation in the World

Page 10 - Ivir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ivir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ivir Today - Breaking & Trending Today

Why VIR is crucial for IMSA's GT title hopefuls - Vimarsana News

Why VIR is crucial for IMSA's GT title hopefuls

Virginia International Raceway plays host to the IMSA WeatherTech SportsCar Championship's second GT-only race of the year, the Michelin GT Challenge, where 20 GTD PRO and GTD drivers get to slug it out without constantly checking their mirrors for ...

Source: yahoo.com
FOXNEWS Gutfeld June 4, 2024 07:56:00 - Vimarsana News

FOXNEWS Gutfeld June 4, 2024 07:56:00

Every first statement, every first question, every first answer, every first reaction. because to be this country's next president, you only get one first impression. >> the first republican primary debate. martha maccallum and bret, moderate america is watching. >> back in my day, we don't have all of these types of fancy chicken for sure. you have wings and fried chicken. well, we didn't have garlic farm or sweet barbecue and he had to walk uphill both ways. >> and it's every time. hydr >> yeah, right where i'm hereat from my do you ever feeler alo dehydrated and need to feel betternelicious...

VIR tees up "Swing For the Kids" - Vimarsana News

VIR tees up "Swing For the Kids"

An annual charity golf tournament organised by VIR in October hopes to bring opportunity to disadvantaged students across the country.

Source: vir.com.vn
Vir Biotechnology (NASDAQ:VIR) Receives Buy Rating from Needham & Company LLC - Vimarsana News

Vir Biotechnology (NASDAQ:VIR) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $22.00 price target on the stock. Several other equities research analysts also recently commented on the stock. HC Wainwright reaffirmed a buy rating and set […]

Vir Biotechnology (NASDAQ:VIR) Issues Earnings Results - Vimarsana News

Vir Biotechnology (NASDAQ:VIR) Issues Earnings Results

Vir Biotechnology (NASDAQ:VIR – Get Free Report) released its earnings results on Thursday. The company reported ($1.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.21) by ($0.24), Briefing.com reports. The business had revenue of $3.80 million during the quarter, compared to analysts’ expectations of $22.39 million. The company’s quarterly revenue […]